`Immunologic memoryâ behind HIV inflammation: Study
Patients living with HIV are at an increased risk of developing chronic inflammation due to âimmunologic memory,â according to a study
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Patients living with HIV are at an increased risk of developing chronic inflammation due to âimmunologic memory,â according to a study
Some vitamins can have fatal side-effects as a new study finds that Niacin may carry risk of brain cancer
The WHO is preparing for an unknown âDisease Xâ epidemic by convening more than 300 global scientists to draw evidence from more than.
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.
About 45% of the worldâs population, or 3.5 billion people, are suffering from oral diseases, a new study states.
WHO drafts an agreement for pharma companies to disclose contract terms for emergency vaccines
Antimalarial drug resistance in Africa is a severe cause for concern and parasite resistance to artemisinin medicine has emerged in the Greater Mekong.
Scientists have developed a vaccine against fentanyl addiction that works in rats and is ready for human trials
Mild Covid can reactivate latent viruses, especially in people suffering from chronic fatigue syndrome